Related references
Note: Only part of the references are listed.ALDHhigh adenoid cystic carcinoma cells display cancer stem cell properties and are responsible for mediating metastasis
Shuyang Sun et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy (ALDH7A1 deficiency)
Philippa B. Mills et al.
BRAIN (2010)
Aldehyde Dehydrogenase 1 A1-Positive Cell Population Is Enriched in Tumor-Initiating Cells and Associated with Progression of Bladder Cancer
Yun Su et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
High Aldehyde Dehydrogenase Activity Identifies Tumor-Initiating and Metastasis-Initiating Cells in Human Prostate Cancer
Christel van den Hoogen et al.
CANCER RESEARCH (2010)
Aldehyde Dehydrogenase 1-Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer
Emmanuelle Charafe-Jauffret et al.
CLINICAL CANCER RESEARCH (2010)
Retinoic acid directs neuronal differentiation of human pluripotent stem cell lines in a non-cell-autonomous manner
Peter D. Tonge et al.
DIFFERENTIATION (2010)
Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma
Shilpa Lingala et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2010)
Activation of retinoic acid receptor signaling coordinates lineage commitment of spontaneously differentiating mouse embryonic stem cells in embryoid bodies
Zoltan Simandi et al.
FEBS LETTERS (2010)
Human breast milk is a rich source of multipotent mesenchymal stem cells
Satish Patki et al.
HUMAN CELL (2010)
Prognostic Significance of Tumorigenic Cells With Mesenchymal Features in Pancreatic Adenocarcinoma
Zeshaan A. Rasheed et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
All-trans retinoic acid promotes smooth muscle cell differentiation of rabbit bone marrow-derived mesenchymal stem cells
Zhong-yuan Su et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2010)
ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome
Ting Li et al.
LABORATORY INVESTIGATION (2010)
CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells
M-Q Gao et al.
ONCOGENE (2010)
Distinct Expression Levels and Patterns of Stem Cell Marker, Aldehyde Dehydrogenase Isoform 1 (ALDH1), in Human Epithelial Cancers
Shan Deng et al.
PLOS ONE (2010)
Aldehyde Dehydrogenase (ALDH) Activity Does Not Select for Cells with Enhanced Aggressive Properties in Malignant Melanoma
Lina Prasmickaite et al.
PLOS ONE (2010)
Retinoic acid modulates retinaldehyde dehydrogenase 1 gene expression through the induction of GADD153-C/EBPβ interaction
Guillermo Elizondo et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Aldehyde dehydrogenase 1a1 is dispensable for stem cell function in the mouse hematopoietic and nervous systems
Boaz P. Levi et al.
BLOOD (2009)
Revascularization of ischemic limbs after transplantation of human bone marrow cells with high aldehyde dehydrogenase activity
Benjamin J. Capoccia et al.
BLOOD (2009)
Aldehyde Dehydrogenase-Expressing Colon Stem Cells Contribute to Tumorigenesis in the Transition from Colitis to Cancer
Joseph E. Carpentino et al.
CANCER RESEARCH (2009)
Aldehyde Dehydrogenase 1 Is a Marker for Normal and Malignant Human Colonic Stem Cells (SC) and Tracks SC Overpopulation during Colon Tumorigenesis
Emina H. Huang et al.
CANCER RESEARCH (2009)
Retinoid signaling regulates breast cancer stem cell differentiation
Christophe Ginestier et al.
CELL CYCLE (2009)
Aldehyde dehydrogenase activity as a functional marker for lung cancer
Deniz Ucar et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2009)
Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers
Tomonori Tanei et al.
CLINICAL CANCER RESEARCH (2009)
The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer
Virginia Tirino et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2009)
If cancer stem cells are resistant to current therapies, what's next?
Paola Marcato et al.
FUTURE ONCOLOGY (2009)
Human Progenitor Cells with High Aldehyde Dehydrogenase Activity Efficiently Engraft into Damaged Liver in a Novel Model
Ping Zhou et al.
HEPATOLOGY (2009)
High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability
Alysha K. Croker et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Interaction of the SPG21 protein ACP33/maspardin with the aldehyde dehydrogenase ALDH16A1
Michael C. Hanna et al.
NEUROGENETICS (2009)
Targeting aldehyde dehydrogenase: a potential approach for cell labeling
Ganesan Vaidyanathan et al.
NUCLEAR MEDICINE AND BIOLOGY (2009)
Human aldehyde dehydrogenase genes: alternatively spliced transcriptional variants and their suggested nomenclature
William J. Black et al.
PHARMACOGENETICS AND GENOMICS (2009)
Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment
Giulia Bertolini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Fibroblastic Colony-Forming Unit Bone Marrow Cells Delay Progression to Gastric Dysplasia in a Helicobacter Model of Gastric Tumorigenesis
Sophie S. W. Wang et al.
STEM CELLS (2009)
High Aldehyde Dehydrogenase Activity: A Novel Functional Marker of Murine Prostate Stem/Progenitor Cells
Patricia E. Burger et al.
STEM CELLS (2009)
ALDH1 as a Functional Marker of Cancer Stem and Progenitor Cells
Julie Douville et al.
STEM CELLS AND DEVELOPMENT (2009)
Significance of CD90+ cancer stem cells in human liver cancer
Zhen Fan Yang et al.
CANCER CELL (2008)
The Role of CD133 in Normal Human Prostate Stem Cells and Malignant Cancer-Initiating Cells
Donald J. Vander Griend et al.
CANCER RESEARCH (2008)
Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily
Satori A. Marchitti et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2008)
CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL
Y. Kong et al.
LEUKEMIA (2008)
Overexpression of stem cell associated ALDH1A1, a target of the leukemogenic transcription factor TLX1/HOX11, inhibits lymphopoiesis and promotes myelopoiesis in murine hematopoietic progenitors
Kim L. Rice et al.
LEUKEMIA RESEARCH (2008)
Widespread nonhematopoietic tissue distribution by transplanted human progenitor cells with high aldehyde dehydrogenase activity
David A. Hess et al.
STEM CELLS (2008)
Aldehyde Dehydrogenase as a Marker for Stem Cells
Jan S. Moreb
CURRENT STEM CELL RESEARCH & THERAPY (2008)
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Jane E. Visvader et al.
NATURE REVIEWS CANCER (2008)
Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy
Christine M. Fillmore et al.
BREAST CANCER RESEARCH (2008)
Defining the transcriptional signature of skeletal muscle stem cells1,2
Z. Yablonka-Reuveni et al.
JOURNAL OF ANIMAL SCIENCE (2007)
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
Christophe Ginestier et al.
CELL STEM CELL (2007)
Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer
Patrick C. Hermann et al.
CELL STEM CELL (2007)
The combined use of Hoechst efflux ability and aldehyde dehydrogenase activity to identify murine and human hematopoietic stem cells
Daniel J. Pearce et al.
EXPERIMENTAL HEMATOLOGY (2007)
CD133+ and CD133- glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles
Dagmar Beier et al.
CANCER RESEARCH (2007)
Identification of pancreatic cancer stem cells
Chenwei Li et al.
CANCER RESEARCH (2007)
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
Catherine A. O'Brien et al.
NATURE (2007)
Identification and expansion of human colon-cancer-initiating cells
Lucia Ricci-Vitiani et al.
NATURE (2007)
Sjogren-Larsson syndrome: Molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency
William B. Rizzo
MOLECULAR GENETICS AND METABOLISM (2007)
Intrinsic retinoic acid receptor alpha-cyclin-dependent kinase-activating kinase signaling involves coordination of the restricted proliferation and granulocytic differentiation of human hematopoietic stem cells
Peihua Luo et al.
STEM CELLS (2007)
Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens
Jun Miki et al.
CANCER RESEARCH (2007)
RNAi-mediated knockdown of aldehyde dehydrogenase class-1A1 and class-3A1 is specific and reveals that each contributes equally to the resistance against 4-hydroperoxycyclophosphamide
Jan S. Moreb et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
Extended passaging, but not aldehyde dehydrogenase activity, increases the chondrogenic potential of human adipose-derived adult stem cells
Radley T. Estes et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Integrins are markers of human neural stem cells
Peter E. Hall et al.
STEM CELLS (2006)
Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells
John P. Chute et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity
Stefania Corti et al.
STEM CELLS (2006)
Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells
DA Hess et al.
BLOOD (2006)
Cancer stem cells: An old idea - A paradigm shift
MS Wicha et al.
CANCER RESEARCH (2006)
CD44(+)/CD24(-) breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis
Carol Sheridan et al.
BREAST CANCER RESEARCH (2006)
Prospective identification of tumorigenic prostate cancer stem cells
AT Collins et al.
CANCER RESEARCH (2005)
Analysis of ALDH1A2, CYP26A1, CYP26B1, CRABP1, and CRABP2 in human neural tube defects suggests a possible association with alleles in ALDH1A2
KL Deak et al.
BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY (2005)
Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34
RW Storms et al.
BLOOD (2005)
Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties
D Ponti et al.
CANCER RESEARCH (2005)
Retinoic acid down-regulates aldehyde dehydrogenase and increases cytotoxicity of 4-hydroperoxycyclophosphamide and acetaldehyde
JS Moreb et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity
DA Hess et al.
BLOOD (2004)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
Membrane properties of rat embryonic multipotent neural stem cells
JL Cai et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Phenotypic characterization of murine primitive hematopoietic progenitor cells isolated on basis of aldehyde dehydrogenase activity
L Armstrong et al.
STEM CELLS (2004)
Retinoids run rampant: Multiple roles during spinal cord and motor neuron development
B Appel et al.
NEURON (2003)
Mobilized peripheral blood SSCloALDHbr cells have the phenotypic and functional properties of primitive haematopoietic cells and their number correlates with engraftment following autologous transplantation
P Fallon et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Cytosolic retinoid dehydrogenases govern ubiquitous metabolism of retinol to retinaldehyde followed by tissue-specific metabolism to retinoic acid
G Duester et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2003)
Human aldehyde dehydrogenases: Potential pathological, pharmacological, and toxicological impact
NE Sladek
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2003)
Classification of sensitivity or resistance of cervical cancers to ionizing radiation according to expression profiles of 62 genes selected by cDNA microarray analysis
O Kitahara et al.
NEOPLASIA (2002)
Effects of alcohol intake on ambulatory blood pressure, heart rate, and heart rate variability in Japanese men with different ALDH2 genotypes
J Minami et al.
JOURNAL OF HUMAN HYPERTENSION (2002)
Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer:: a retrospective study -: Rational individualization of oxazaphosphorine-based cancer chemotherapeutic regimens
NE Sládek et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2002)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)
Primary breast tumor levels of suspected molecular determinants of cellular sensitivity to cyclophosphamide, ifosfamide, and certain other anticancer agents as predictors of paired metastatic tumor levels of these determinants -: Rational individualization of cancer chemotherapeutic regimens
L Sreerama et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2001)
Generation of dual resistance to 4-hydroperoxycyclophosphamide and methotrexate by retroviral transfer of the human aldehyde dehydrogenase class 1 gene and a mutated dihydrofolate reductase gene
N Takebe et al.
MOLECULAR THERAPY (2001)
Feedback inhibition of the retinaldehyde dehydrogenase gene ALDH1 by retinoic acid through retinoic acid receptor A and CCAAT/enhancer-binding protein β
G Elizondo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Inactivation of aldophosphamide by human aldehyde dehydrogenase isozyme 3
F Giorgianni et al.
BIOCHEMICAL PHARMACOLOGY (2000)
Polymorphisms of human aldehyde dehydrogenases - Consequences for drug metabolism and disease
V Vasiliou et al.
PHARMACOLOGY (2000)
Share Paper
